Stakeholders Say Codex Emergency Food Labeling Provisions Could Compromise Infant Formula Safety

Why It Matters

The outcome will shape how quickly emergency‑relief foods, especially infant formula, can reach markets without compromising safety, setting a precedent for global food‑labeling governance.

Key Takeaways

• Draft Codex guidelines permit temporary labeling flexibilities during emergencies.
• IBFAN and ENCA warn flexibilities could endanger infants and children.
• Recent formula recalls highlight risks of inadequate labeling in crises.
• U.S. FDA previously used enforcement discretion to alleviate formula shortages.
• Guidelines require time‑limited, risk‑based measures and clear public communication.

Pulse Analysis

The Codex Committee on Food Labeling’s upcoming session reflects growing pressure to balance rapid food distribution with consumer protection. The draft emergency‑labeling guidelines, spearheaded by the United States, aim to create a structured pathway for temporary deviations from standard labeling when supply chains are strained by pandemics, conflicts, or natural disasters. By defining emergencies, setting proportionality thresholds, and mandating traceability, the proposal seeks to prevent bottlenecks that could exacerbate shortages while preserving a baseline of safety.

Critics from infant‑health advocacy groups argue that any relaxation of labeling standards threatens the most vulnerable consumers. Past incidents—such as COVID‑era formulas falsely touting immunity, mislabeled “Recover” products distributed after Pakistan’s 2022 floods, and the 2026 global recall linked to contaminated arachidonic‑acid oil—demonstrate how inadequate labeling can obscure hazards, hinder recalls, and erode public trust. For infant formula, precise ingredient and allergen information is essential; even brief lapses can lead to severe health outcomes, including botulism and Cronobacter infections.

If adopted, the guidelines could become a benchmark for emergency food governance worldwide, compelling national authorities to document, monitor, and withdraw flexibilities once crises subside. Industry players would need robust internal controls to ensure that temporary label changes remain risk‑based and transparent, while regulators must coordinate with networks like WHO’s INFOSAN to disseminate decisions swiftly. Ultimately, the balance struck will influence both the speed of humanitarian food aid and the integrity of consumer safety standards in future emergencies.